Nurix Therapeutics annual total assets
2019
2020
2021
2022
2023
2024
2025
Nurix Therapeutics Total Assets Growth & History (NRIX)
Nurix Therapeutics's total assets was $688.1M for fiscal 2025.
View full Nurix Therapeutics company overviewNurix Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-11-30 | $688.1M | $18.8M | +2.81% |
| 2024 | 2024-11-30 | $669.3M | $313.7M | +88.23% |
| 2023 | 2023-11-30 | $355.6M | −$61.2M | −14.68% |
| 2022 | 2022-11-30 | $416.8M | −$60.0M | −12.59% |
| 2021 | 2021-11-30 | $476.8M | $80.4M | +20.29% |
| 2020 | 2020-11-30 | $396.3M | $352.3M | +799.80% |
| 2019 | 2019-11-30 | $44.0M | — | — |
Nurix Therapeutics quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-05-31 | $535.5M | −$56.0M | −9.47% |
| Q1 2026 | 2026-02-28 | $636.1M | $21.1M | +3.43% |
| Q4 2025 | 2025-11-30 | $688.1M | $18.8M | +2.81% |
| Q3 2025 | 2025-08-31 | $522.5M | $8.9M | +1.73% |
| Q2 2025 | 2025-05-31 | $591.6M | $80.5M | +15.76% |
| Q1 2025 | 2025-02-28 | $615.0M | $302.4M | +96.70% |
| Q4 2024 | 2024-11-30 | $669.3M | $313.7M | +88.23% |
| Q3 2024 | 2024-08-31 | $513.6M | $205.4M | +66.65% |
| Q2 2024 | 2024-05-31 | $511.0M | $160.4M | +45.75% |
| Q1 2024 | 2024-02-29 | $312.7M | −$57.5M | −15.53% |
| Q4 2023 | 2023-11-30 | $355.6M | −$61.2M | −14.68% |
| Q3 2023 | 2023-08-31 | $308.2M | −$151.1M | −32.90% |
| Q2 2023 | 2023-05-31 | $350.6M | −$43.7M | −11.08% |
| Q1 2023 | 2023-02-28 | $370.2M | −$67.6M | −15.44% |
| Q4 2022 | 2022-11-30 | $416.8M | −$60.0M | −12.59% |
| Q3 2022 | 2022-08-31 | $459.3M | −$33.7M | −6.84% |
| Q2 2022 | 2022-05-31 | $394.3M | −$123.7M | −23.88% |
| Q1 2022 | 2022-02-28 | $437.7M | $41.1M | +10.35% |
| Q4 2021 | 2021-11-30 | $476.8M | $80.4M | +20.29% |
| Q3 2021 | 2021-08-31 | $493.1M | $81.2M | +19.71% |
| Q2 2021 | 2021-05-31 | $518.0M | — | — |
| Q1 2021 | 2021-02-28 | $396.7M | — | — |
| Q4 2020 | 2020-11-30 | $396.3M | $352.3M | +799.80% |
| Q3 2020 | 2020-08-31 | $411.9M | — | — |
| Q4 2019 | 2019-11-30 | $44.0M | — | — |
Nurix Therapeutics total assets trends
Over the last five fiscal years, Nurix Therapeutics's total assets increased from $396.3M to $688.1M, a change of $291.8M. The latest reported quarter, Q2 2026, shows $535.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nurix Therapeutics source filings ↗